Facet Biotech Receiving $15 Million From Partner - Yahoo! Finance
REDWOOD CITY, Calif. (AP) -- Facet Biotech Corp. said Monday it will receive a $15 million payment from Bristol-Myers Squibb Co. for work on a potential
Facet Biotech Receiving $15 Million From Partner - Yahoo! Finance
Facet Biotech Corp - Form 8-k - Ex-99.2 - February 26, 2010
Good day and welcome to the Facet Biotech fourth quarter and full year 2009 financial results conference call. Today's call is being recorded.
Facet Biotech Corp - Form 8-k - Ex-99.2 - February 26, 2010
Zacks Analyst Blog Highlights: Facet Biotech Corporation, Biogen Idec
Zacks Analyst Blog Highlights: Facet Biotech Corporation, Biogen Idec Inc., Trubion Pharmaceuticals, Bristol-Myers Squibb and Acorda Therapeutics-Zacks Analyst Blog Highlights
Zacks Analyst Blog Highlights: Facet Biotech Corporation, Biogen Idec
Facet Biotech Corp Files Sec Form 10-q, Quarterly Report
Facet Biotech was organized as a Delaware corporation in July 2008 by PDL BioPharma, Inc.
However, Facet Biotech had not conducted any operations prior to the Spin-off.
Facet Biotech Corp Files Sec Form 10-q, Quarterly Report
Facet Biotech Announces Enrollment Of First Patient In Phase 2 Study
Facet Biotech Announces Enrollment of First Patient in Phase 2 Study of Elotuzumab in Patients With Relapsed Multiple Myeloma. - REDWOOD CITY, CA--(Marketwire - 01/11/10) - Facet
Facet Biotech Announces Enrollment Of First Patient In Phase 2 Study
Facet Biotech Receiving $15 Million From Partner - Boston.com
Facet Biotech Corp. said Monday it will receive a $15 million payment from Bristol-Myers Squibb Co. for work on a potential cancer drug.
Facet Biotech Receiving $15 Million From Partner - Boston.com
Facet Biotech Jobs - Washingtonpost.com
Facet Biotech jobs from washingtonpost.com. Search all Facet Biotech jobs to find the best career for you.
Facet Biotech Jobs - Washingtonpost.com
Facet Biotech: Open For Bidding
The biotech sector has been a hot one this year. That's good news for the companies on the auction block and bad news for the bidders.
Facet Biotech: Open For Bidding
Facet Biotech To Present At 12th Annual Bio Ceo & Investor Conference
REDWOOD CITY, CA--(Marketwire - February 2, 2010) - Facet Biotech Corporation (NASDAQ: FACT) today announced that the company will participate at the 2010 BIO CEO & Investor
Facet Biotech To Present At 12th Annual Bio Ceo & Investor Conference
Biogen Idec Makes Hostile $350m Takeover Bid For Facet Biotech
Biogen Idec isn't sitting around waiting to get acquired---it wants to be the acquirer. The Cambridge, MA-based biotech company said today it is making an
Biogen Idec Makes Hostile $350m Takeover Bid For Facet Biotech
Biogen Idec Threatens Proxy Battle For Facet - Fiercebiotech
With the clock ticking to a midnight tender offer deadline today, Biogen Idec threatened to get out the brass knuckles to complete its bid to acquire Facet Biotech.
Biogen Idec Threatens Proxy Battle For Facet - Fiercebiotech
I pre-moderate first-time commenters. Please review my comment policy before leaving a comment.
Friends
No Friends Yet :(
Be the First! Mail me at
admin [doggy] presidentnews.info